cancer were 0.29 (0.24-0.36) for post-ad, 0.81 (0.61-1.07) for post-crc, and 2.77 (2.43-3.17) for positive FOBT. Conclusion: Colonoscopy for post-ad surveillance but not colonoscopy for post-crc surveillance is associated with a lower risk of diagnosis of advanced adenoma and cancer.
cancer is comparable with the rate of cancers detected upon screening colonoscopy [8] . Studies on the risk of metachronous cancer after polypectomy have yielded discordant results: some studies have reported an increased risk [10] [11] [12] [13] [14] , others have reported a reduced risk [6, [15] [16] [17] .
So far the frequency and risk of metachronous cancer and advanced adenoma upon post-cancer and post-adenoma surveillance have not been assessed in the same study. To determine the risk of advanced adenoma and cancer in surveillance colonoscopies, we analyzed a large sample of colonoscopies done for surveillance after curative resection of colorectal cancer or removal of colonic adenomas. We determined the relative frequencies of findings and calculated the risk of advanced adenoma and cancer in surveillance colonoscopies.
Material and Methods

Colonoscopy Registry
The Bavarian Association of Compulsory Health Insurance (CHI) Physicians documents all outpatient colonoscopies in a central database. Only endoscopists with a documented experience of ≥ 200 colonoscopies and ≥ 50 polypectomies within the past 2 years and a continuously high volume of colonoscopies and polyp ectomies are certified to perform colonoscopies in outpatients insured by the CHI system covering about 83% of the Bavarian population. Online documentation is required for reimbursement. No individual patient identification data are contained in the database and data collection has been approved by the Bavarian governmental authority for data protection. For this analysis, datasets of all colonoscopies performed in adults for primary screening, for follow-up on a positive FOBT, for post-cancer or post-adenoma surveillance between January 2006 and December 2008 were available. The findings on colonoscopy were categorized on the basis of the most advanced lesion found. Colonoscopies done in individuals younger than 18 years, individuals with a history of chronic inflammatory bowel disease, individuals with increased family risk, and repeat examinations were excluded from analysis. In case of repeat examinations only the index colonoscopy was included. Advanced adenoma was defined as adenoma that was at least 10 mm in diameter, had high-grade dysplasia, had villous or tubulovillous histologic characteristics, or any combination thereof.
Statistical Analysis
Distributions of characteristics of patients, colonoscopies, complications, and detected lesions were described using absolute and relative frequencies. Adenoma detection rates were defined as the proportions of subjects in whom at least one adenoma was identified. We modeled the risks of advanced adenoma and cancer in patients with lesions using logistic regression models including the following fixed set of independent variables: lesion count, size of the largest lesion, localization of the largest lesion, gender, age, age squared, age cubed, and indication for colonoscopy. All analyses were performed using SAS version 9.2 for Linux (SAS Institute, Inc., Cary, N.C., USA).
Results
For this analysis, a total of 324,912 colonoscopies performed in adults were included ( ( table 3 ) . The adenoma detection rates of all colonoscopies were 27.5%: 24.9% for screening colonoscopies, 26.3% for work-ups for positive FOBT, 35.9% for post-adenoma surveillance, and 20.7% for post-cancer surveillance ( fig. 1 ). Of the 178,305 screening colonoscopies, 31,084 (17.43%) reported non-advanced adenomas, 13,215 (7.41%) reported advanced adenomas, and 1,865 (1.05%) reported cancers as the most advanced lesion found. 5,513 (14.57%) of the 37,834 colonoscopies done for follow-up of a positive FOBT identified non-advanced adenomas, 4,432 (11.71%) advanced adenomas, and 1,369 (3.62%) cancers. 81,877 colonoscopies done for postadenoma surveillance revealed 22,815 (27.87%) non-advanced adenomas, 6,583 (8.04%) advanced adenomas, and 297 (0.36%) cancers. The 26,896 colonoscopies performed for post-cancer surveillance identified 4,209 (15.65%) non-advanced adenomas, 1,350 (5.02%) advanced adenomas, and 277 (1.03%) cancers.
Logistic regression was performed to identify the risk for cancer and advanced adenoma in surveillance colonoscopies ( fig. 2 ) 
Discussion
The present study is based on a large cohort of routine surveillance colonoscopies done in unselected individuals. The study analyzes the risk of advanced adenoma and cancer in post-cancer and post-adenoma surveillance in parallel to screening colonoscopies, representing a group of individuals at average risk, and colonoscopies done for work-up of positive FOBTs, representing a group at increased risk. Colonoscopies done in individuals with a known increased family risk for colorectal cancer were excluded to avoid a bias due to different basic risks. The quality of the colonoscopies documented in the database is highly reflected by a low complication rate, a high rate of complete examinations, and adenoma detection rates above 20%. We demonstrate that colonoscopies done for post-adenoma surveillance are associated with a reduced risk of advanced adenoma and cancer compared to screening colonoscopy. Individuals undergoing postcancer surveillance have a similar risk for advanced adenoma and cancer as individuals undergoing screening. As expected, colonoscopies done for follow-up of a positive FOBT, representing a high-risk group, had the highest risk for advanced adenoma and cancer.
An adenoma detection rate of 20% or higher has been demonstrated to be associated with the lowest risk of interval colorectal cancer after screening colonoscopy [18] . In the same study the cecal intubation rate was not significantly associated with this risk. The adenoma detection rate was above 20% in all of the four colonoscopy indication groups in our study, demonstrating the high quality of the colonoscopists. However, it was highest in the post-adenoma surveillance group with 35.9% and lowest in the post-cancer surveillance group with 20.7%. As these colonoscopies have been performed by the same endoscopists there is no reason to assume a difference in the quality of the colonoscopies. A potential and possibly most likely explanation for the lowest adenoma detection rate in the post-cancer surveillance group is the status of partial or hemicolectomy due to the history of cancer resulting in a reduced total colonic surface. The high adenoma detection rate in the post-adenoma surveillance group is mainly due to the high number of non-advanced adenomas resulting in a non-advanced-to-advanced adenoma ratio of 3.5 compared to a ratio of 2.4 in the screening group. An even higher adenoma detection rate of 39.7% and a similarly high ratio of 2.9 have previously been reported in a cohort of post-adenoma surveillance colonoscopies [14] .
The rationale for surveillance after polypectomy is that size, number and histology of adenoma at baseline colonoscopy indicate the risk for the development of metachronous cancer and advanced adenoma [9] . We find that colonoscopies performed for post-adenoma surveillance are associated with a significantly lower risk of finding cancer or advanced adenoma than screening colonoscopies. This might indicate a protective effect of clearing the colon of adenomas during a prior colonoscopy. Our frequencies of findings are in line with other studies, for example Cottet et al. [14] reported on 4,881 colonoscopies done for surveillance after removal of adenoma: 29.6% colonoscopies revealed a non-advanced adenoma, 10.1% an advanced adenoma, and 0.1% cancer as the most advanced lesion found. The researchers of the National Polyp Study reported on 26.6% non-advanced adenomas upon the first surveillance colonoscopy and 20.7% non-advanced adenomas upon the second surveillance colonoscopy [19] . However, the rates of advanced adenoma were 2.9 and 0.9% in this study, respectively. This stands in strong contrast to our and Cottet's findings and is most likely due to the fact that the numbers reported by Winawer et al. [19] are based on a trial while our and Cottet's studies are based on routine colonoscopies. Still the high rate of non-advanced adenomas in all three studies may be explained by an increased risk for developing adenoma after polypectomy supporting the surveillance recommendations. Furthermore, due to surveillance, these earlier adenomas might not have had the time to advance in size and towards more severe histological abnormalities. Another issue that needs to be discussed in this context is that colonoscopy misses a substantial number of small lesions as has been demonstrated by back-to-back colonoscopy studies [20] . Therefore, it cannot be excluded that the high number of nonadvanced adenomas in the surveillance groups is at least in part due to failure of colonoscopy to detect and remove these lesions at baseline colonoscopy. We find a strongly reduced risk of cancer in the post-adenoma surveillance group compared to the screening group which can be assumed to be at average risk. Cottet et al. [14] reported on an increased risk of colorectal cancer after polypectomy compared to the expected number of cases. However, a significant difference was only seen in the group of individuals with advanced adenoma at baseline colonoscopy who did not have surveillance colonoscopy but not in the group that received surveillance colonoscopies. This group was shown to be at similar risk as the general population. Several other studies have also reported on the cancer risk after removal of adenoma. Studies reporting on cohorts of populations without surveillance have reported on an increased risk [10] [11] [12] [13] while a reduced risk has been reported in studies with systematic surveillance after polypectomy [6, [15] [16] [17] . Therefore, polypectomy in combination with surveillance colonoscopy and not polypectomy alone appears to reduce the risk of colorectal cancer.
Surveillance colonoscopy in patients after resection of colorectal cancer intends to detect early recurrences of the resected cancers and to detect metachronous cancers [20] . Anastomotic recurrences have been demonstrated to be less frequent in colon than in rectal cancer patients. It has been shown that the risk of a second colorectal cancer remains high after curative resection of colorectal cancer [21] . A meta-analysis has found that the rate of metachronous cancers detected upon surveillance compares very well with the rate of prevalent cancers detected during screening colonoscopy [20] . However, some of the cancers detected, especially those detected early after resection, may represent synchronous lesions missed at the time of the initial diagnosis. There are at least three potential reasons for the higher cancer rate in the post-cancer than in the post-adenoma surveillance group: (1) compliance with surveillance recommendations may have differed between groups; (2) patients with a history of cancer may differ biologically from patients with adenomatous polyps and may therefore have a higher risk, and (3) clearing of the colon from adenoma may not have been as rigorous in the initial colonoscopy in the cancer as in the adenoma group. Our study does not give the answer, however it reconfirms the necessity for surveillance after surgery for colorectal cancer. Future studies need to clarify this dilemma and how to further reduce the risk of metachronous cancer.
Three major issues related to the database underlying this analysis limit the conclusions that may be drawn from this study. First, we do not know the time interval since resection of the cancer or removal of the adenoma and surveillance colonoscopy. Furthermore, we do not know whether the surveillance colonoscopy documented in the database was the first or a repeat examination after resection of the cancer or removal of the adenoma. The risk of advanced adenoma and cancer may be different in a first compared to a repeat surveillance colonoscopy. Therefore, our study is only able to give mean numbers for first and repeat surveillance colonoscopies. Future database documentation should account for this. Second, our study is a retrolective analysis of routine data not primarily collected for scientific purposes, such as the analysis of risk for advanced adenoma and cancer in surveillance colonoscopies. A negative consequence of this is that we neither know the stage of the original tumor in the post-cancer surveillance group, nor the size, number and histology of adenomas removed in the post-adenoma surveillance group. As size, histology, and multiplicity of the polyps removed at baseline colonoscopy predict the subsequent detection of advanced adenomas [9] , this would have been important information. Accordingly, guidelines recommend surveillance colonoscopy 3 years after removal of advanced adenomas and 5 years after removal of non-advanced adenomas. Moreover, patients with 3 or more adenomas of any size are also assumed at increased risk of advanced adenomas and therefore recommended surveillance colonoscopy after 3 years [9] . This limitation can best be overcome by prospective studies. Documentation of this information in the database would improve future analyses. Third, another limitation is that histology was performed by local pathologists and not subject to central review. Systematic over-or underreading of advanced histology could introduce bias. However, in another study employing central pathology review of local pathology interpretation, a systematic bias was not detected [22] .
In conclusion, this study demonstrates that the risk of advanced adenoma and cancer remains at the same level after resection of cancer as in an average risk population undergoing screening colonoscopy. This reinforces the importance of regular surveillance in this subgroup of patients. Furthermore, the risk of advanced adenoma is slightly and the risk of cancer is strongly reduced in individuals after prior removal of colorectal adenoma. The strong reduction of risk for colorectal cancer lends further support to the efficacy of colonoscopy in combination with polypectomy in preventing colorectal cancer. As the risk for advanced adenoma is only slightly reduced in this subgroup of patients and advanced adenomas bear a high potential of malignant transformation, surveillance colonoscopies also need to be done regularly in this subgroup.
